Loading…

CIB1: a small protein with big ambitions

ABSTRACT Calcium‐ and integrin‐binding protein 1 (CIB1) is a small, ubiquitously expressed protein that was first identified as an intracellular binding partner of a platelet‐specific α‐integrin cytoplasmic tail. Although early studies revealed a role for CIB1 in regulating platelet integrin activit...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2016-08, Vol.30 (8), p.2640-2650
Main Authors: Leisner, Tina M., Freeman, Thomas C., Black, Justin L., Parise, Leslie V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3
cites cdi_FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3
container_end_page 2650
container_issue 8
container_start_page 2640
container_title The FASEB journal
container_volume 30
creator Leisner, Tina M.
Freeman, Thomas C.
Black, Justin L.
Parise, Leslie V.
description ABSTRACT Calcium‐ and integrin‐binding protein 1 (CIB1) is a small, ubiquitously expressed protein that was first identified as an intracellular binding partner of a platelet‐specific α‐integrin cytoplasmic tail. Although early studies revealed a role for CIB1 in regulating platelet integrin activity, recent studies have indicated a more diverse role for CIB1 in many different cell types and processes, including calcium signaling, migration, adhesion, proliferation, and survival. Increasing evidence also points to a novel role for CIB1 in cancer and cardiovascular disease. In addition, an array of CIB1 binding partners has been identified that provide important insight into how CIB1 may regulate these processes. Some of these binding partners include the serine/threonine kinases, p21‐activated kinase 1 (PAK1), apoptosis signal‐regulating kinase 1 (ASK1), and polo‐like kinase 3 (PLK3). Structural and mutational studies indicate that CIB1 binds most or all of its partners via a well‐defined hydrophobic cleft. Although CIB1 itself lacks known enzymatic activity, it supports the PI3K/AKT and MEK/ERK oncogenic signaling pathways, in part, by directly modulating enzymes in these pathways. In this review, we discuss our current understanding of CIB1 and key questions regarding structure and function and how this seemingly diminutive protein impacts important signaling pathways and cellular processes in human health and disease.—Leisner, T. M., Freeman, T. C., Black, J. L., Parise, L. V. CIB1: a small protein with big ambitions. FASEB J. 30, 2640‐2650 (2016). www.fasebj.org
doi_str_mv 10.1096/fj.201500073R
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4970603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1811893831</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3</originalsourceid><addsrcrecordid>eNqNkU1PAjEQhhujEUSPXs0evSx22qXtamIiRBRDYoJ6brrdFkr2A7eLhH_vGhDxYjzNYZ48mXlfhM4BdwHH7MrOuwRDD2PM6eQAtaFHccgEw4eojUVMQsaoaKET7-cNAxjYMWoRDiAYZ210ORj14TpQgc9VlgWLqqyNK4KVq2dB4qaByhNXu7Lwp-jIqsybs-3soLfh_evgMRw_P4wGd-NQR5xMQqGYFpCkKVMiITpSkaYGUp1CbHRktGbYGmtElADn1goRg0oBmOURMQRS2kG3G-9imeQm1aaoK5XJReVyVa1lqZz8vSncTE7LDxnFHDNMG8HlVlCV70vja5k7r02WqcKUSy9BNL_HVFD4B4qbIIE3EXZQuEF1VXpfGbu7CLD8KkLaufwpouEv9t_Y0d_JN8DNBli5zKz_tsnhS58Mn_b0n0MulFM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808601766</pqid></control><display><type>article</type><title>CIB1: a small protein with big ambitions</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Leisner, Tina M. ; Freeman, Thomas C. ; Black, Justin L. ; Parise, Leslie V.</creator><creatorcontrib>Leisner, Tina M. ; Freeman, Thomas C. ; Black, Justin L. ; Parise, Leslie V.</creatorcontrib><description>ABSTRACT Calcium‐ and integrin‐binding protein 1 (CIB1) is a small, ubiquitously expressed protein that was first identified as an intracellular binding partner of a platelet‐specific α‐integrin cytoplasmic tail. Although early studies revealed a role for CIB1 in regulating platelet integrin activity, recent studies have indicated a more diverse role for CIB1 in many different cell types and processes, including calcium signaling, migration, adhesion, proliferation, and survival. Increasing evidence also points to a novel role for CIB1 in cancer and cardiovascular disease. In addition, an array of CIB1 binding partners has been identified that provide important insight into how CIB1 may regulate these processes. Some of these binding partners include the serine/threonine kinases, p21‐activated kinase 1 (PAK1), apoptosis signal‐regulating kinase 1 (ASK1), and polo‐like kinase 3 (PLK3). Structural and mutational studies indicate that CIB1 binds most or all of its partners via a well‐defined hydrophobic cleft. Although CIB1 itself lacks known enzymatic activity, it supports the PI3K/AKT and MEK/ERK oncogenic signaling pathways, in part, by directly modulating enzymes in these pathways. In this review, we discuss our current understanding of CIB1 and key questions regarding structure and function and how this seemingly diminutive protein impacts important signaling pathways and cellular processes in human health and disease.—Leisner, T. M., Freeman, T. C., Black, J. L., Parise, L. V. CIB1: a small protein with big ambitions. FASEB J. 30, 2640‐2650 (2016). www.fasebj.org</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.201500073R</identifier><identifier>PMID: 27118676</identifier><language>eng</language><publisher>United States: Federation of American Societies for Experimental Biology</publisher><subject>Calcium-Binding Proteins - genetics ; Calcium-Binding Proteins - metabolism ; cancer ; cardiovascular ; Cardiovascular Diseases - metabolism ; Gene Expression Regulation - physiology ; Humans ; kinase ; Neoplasms - metabolism ; Review ; signaling ; structure</subject><ispartof>The FASEB journal, 2016-08, Vol.30 (8), p.2640-2650</ispartof><rights>FASEB</rights><rights>FASEB.</rights><rights>FASEB 2016 FASEB</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3</citedby><cites>FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27118676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leisner, Tina M.</creatorcontrib><creatorcontrib>Freeman, Thomas C.</creatorcontrib><creatorcontrib>Black, Justin L.</creatorcontrib><creatorcontrib>Parise, Leslie V.</creatorcontrib><title>CIB1: a small protein with big ambitions</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>ABSTRACT Calcium‐ and integrin‐binding protein 1 (CIB1) is a small, ubiquitously expressed protein that was first identified as an intracellular binding partner of a platelet‐specific α‐integrin cytoplasmic tail. Although early studies revealed a role for CIB1 in regulating platelet integrin activity, recent studies have indicated a more diverse role for CIB1 in many different cell types and processes, including calcium signaling, migration, adhesion, proliferation, and survival. Increasing evidence also points to a novel role for CIB1 in cancer and cardiovascular disease. In addition, an array of CIB1 binding partners has been identified that provide important insight into how CIB1 may regulate these processes. Some of these binding partners include the serine/threonine kinases, p21‐activated kinase 1 (PAK1), apoptosis signal‐regulating kinase 1 (ASK1), and polo‐like kinase 3 (PLK3). Structural and mutational studies indicate that CIB1 binds most or all of its partners via a well‐defined hydrophobic cleft. Although CIB1 itself lacks known enzymatic activity, it supports the PI3K/AKT and MEK/ERK oncogenic signaling pathways, in part, by directly modulating enzymes in these pathways. In this review, we discuss our current understanding of CIB1 and key questions regarding structure and function and how this seemingly diminutive protein impacts important signaling pathways and cellular processes in human health and disease.—Leisner, T. M., Freeman, T. C., Black, J. L., Parise, L. V. CIB1: a small protein with big ambitions. FASEB J. 30, 2640‐2650 (2016). www.fasebj.org</description><subject>Calcium-Binding Proteins - genetics</subject><subject>Calcium-Binding Proteins - metabolism</subject><subject>cancer</subject><subject>cardiovascular</subject><subject>Cardiovascular Diseases - metabolism</subject><subject>Gene Expression Regulation - physiology</subject><subject>Humans</subject><subject>kinase</subject><subject>Neoplasms - metabolism</subject><subject>Review</subject><subject>signaling</subject><subject>structure</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkU1PAjEQhhujEUSPXs0evSx22qXtamIiRBRDYoJ6brrdFkr2A7eLhH_vGhDxYjzNYZ48mXlfhM4BdwHH7MrOuwRDD2PM6eQAtaFHccgEw4eojUVMQsaoaKET7-cNAxjYMWoRDiAYZ210ORj14TpQgc9VlgWLqqyNK4KVq2dB4qaByhNXu7Lwp-jIqsybs-3soLfh_evgMRw_P4wGd-NQR5xMQqGYFpCkKVMiITpSkaYGUp1CbHRktGbYGmtElADn1goRg0oBmOURMQRS2kG3G-9imeQm1aaoK5XJReVyVa1lqZz8vSncTE7LDxnFHDNMG8HlVlCV70vja5k7r02WqcKUSy9BNL_HVFD4B4qbIIE3EXZQuEF1VXpfGbu7CLD8KkLaufwpouEv9t_Y0d_JN8DNBli5zKz_tsnhS58Mn_b0n0MulFM</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>Leisner, Tina M.</creator><creator>Freeman, Thomas C.</creator><creator>Black, Justin L.</creator><creator>Parise, Leslie V.</creator><general>Federation of American Societies for Experimental Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>201608</creationdate><title>CIB1: a small protein with big ambitions</title><author>Leisner, Tina M. ; Freeman, Thomas C. ; Black, Justin L. ; Parise, Leslie V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Calcium-Binding Proteins - genetics</topic><topic>Calcium-Binding Proteins - metabolism</topic><topic>cancer</topic><topic>cardiovascular</topic><topic>Cardiovascular Diseases - metabolism</topic><topic>Gene Expression Regulation - physiology</topic><topic>Humans</topic><topic>kinase</topic><topic>Neoplasms - metabolism</topic><topic>Review</topic><topic>signaling</topic><topic>structure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leisner, Tina M.</creatorcontrib><creatorcontrib>Freeman, Thomas C.</creatorcontrib><creatorcontrib>Black, Justin L.</creatorcontrib><creatorcontrib>Parise, Leslie V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leisner, Tina M.</au><au>Freeman, Thomas C.</au><au>Black, Justin L.</au><au>Parise, Leslie V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CIB1: a small protein with big ambitions</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2016-08</date><risdate>2016</risdate><volume>30</volume><issue>8</issue><spage>2640</spage><epage>2650</epage><pages>2640-2650</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>ABSTRACT Calcium‐ and integrin‐binding protein 1 (CIB1) is a small, ubiquitously expressed protein that was first identified as an intracellular binding partner of a platelet‐specific α‐integrin cytoplasmic tail. Although early studies revealed a role for CIB1 in regulating platelet integrin activity, recent studies have indicated a more diverse role for CIB1 in many different cell types and processes, including calcium signaling, migration, adhesion, proliferation, and survival. Increasing evidence also points to a novel role for CIB1 in cancer and cardiovascular disease. In addition, an array of CIB1 binding partners has been identified that provide important insight into how CIB1 may regulate these processes. Some of these binding partners include the serine/threonine kinases, p21‐activated kinase 1 (PAK1), apoptosis signal‐regulating kinase 1 (ASK1), and polo‐like kinase 3 (PLK3). Structural and mutational studies indicate that CIB1 binds most or all of its partners via a well‐defined hydrophobic cleft. Although CIB1 itself lacks known enzymatic activity, it supports the PI3K/AKT and MEK/ERK oncogenic signaling pathways, in part, by directly modulating enzymes in these pathways. In this review, we discuss our current understanding of CIB1 and key questions regarding structure and function and how this seemingly diminutive protein impacts important signaling pathways and cellular processes in human health and disease.—Leisner, T. M., Freeman, T. C., Black, J. L., Parise, L. V. CIB1: a small protein with big ambitions. FASEB J. 30, 2640‐2650 (2016). www.fasebj.org</abstract><cop>United States</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>27118676</pmid><doi>10.1096/fj.201500073R</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2016-08, Vol.30 (8), p.2640-2650
issn 0892-6638
1530-6860
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4970603
source Wiley-Blackwell Read & Publish Collection
subjects Calcium-Binding Proteins - genetics
Calcium-Binding Proteins - metabolism
cancer
cardiovascular
Cardiovascular Diseases - metabolism
Gene Expression Regulation - physiology
Humans
kinase
Neoplasms - metabolism
Review
signaling
structure
title CIB1: a small protein with big ambitions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A21%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CIB1:%20a%20small%20protein%20with%20big%20ambitions&rft.jtitle=The%20FASEB%20journal&rft.au=Leisner,%20Tina%20M.&rft.date=2016-08&rft.volume=30&rft.issue=8&rft.spage=2640&rft.epage=2650&rft.pages=2640-2650&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.201500073R&rft_dat=%3Cproquest_pubme%3E1811893831%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472R-8a6c81bdd6a8b2c4a4c3e1dcd19ec4ecc60fefe84b177ff8891ad116f742e21d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1808601766&rft_id=info:pmid/27118676&rfr_iscdi=true